|
|||||
|
|
A multicentre,open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors |
|
| Authors: | Midori Shima Keiji Nogami Sayaka Nagami Seitaro Yoshida Koichiro Yoneyama Akira Ishiguro Takashi Suzuki Masashi Taki |
| Abstract: | |
| Keywords: | bispecific antibody emicizumab haemophilia A non‐inhibitor paediatrics prophylaxis |